Association of soluble ST2 Level with 6-month Mortality and/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism

Association of soluble ST2 Level with 6-month Mortality and/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism

The association of soluble suppression of tumorigenesis-2 (sST2) levels with prognosis in pulmonary embolism (PE) is unknown. This study aimed to investigate the relationship between sST2 levels in patients with acute PE and 6-month mortality and recurrent hospitalizations. This prospective study in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arquivos brasileiros de cardiologia 2024, Vol.121 (2), p.e20230040-e20230040
Hauptverfasser: Gunes, Hakan, Gunes, Handan, Dagli, Musa, Kirişçi, Mehmet, Özbek, Meryem, Atilla, Nurhan, Yılmaz, Mehmet Birhan
Format: Artikel
Sprache:eng ; por
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e20230040
container_issue 2
container_start_page e20230040
container_title Arquivos brasileiros de cardiologia
container_volume 121
creator Gunes, Hakan
Gunes, Handan
Dagli, Musa
Kirişçi, Mehmet
Özbek, Meryem
Atilla, Nurhan
Yılmaz, Mehmet Birhan
description The association of soluble suppression of tumorigenesis-2 (sST2) levels with prognosis in pulmonary embolism (PE) is unknown. This study aimed to investigate the relationship between sST2 levels in patients with acute PE and 6-month mortality and recurrent hospitalizations. This prospective study included 100 patients with acute PE. Patients were classified into two groups according to 6-month mortality and the presence of recurrent Cardiovascular-Related hospitalizations. Two groups were compared. A p-value of 0.05 was considered statistically significant. Soluble ST2 levels were significantly higher in the group with mortality and recurrent hospitalizations. (138.6 ng/mL (56.7-236.8) vs. 38 ng/mL (26.3-75.4); p89.9 with a specificity of 90.6% and a sensitivity of 65.2%, according to the receiver operating characteristic curve (area under the curve = 0.798; 95% CI, 0.705-0.891; p
doi_str_mv 10.36660/abc.20230040
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2934273643</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2934273643</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-e28d7186e74c3c942e55d0c6b6e07b480bbad360fa26d50326be2393e2b09d1c3</originalsourceid><addsrcrecordid>eNo1kDtPwzAUhS0kREthZEUeWdI6duIkY1UVilQEKmWO_LgVRk4cbKeo7Pxvglqms3znoYPQTUqmjHNOZkKqKSWUEZKRMzROeVEmWVqQEboM4YMQSguWX6ARKzM6UPkY_cxDcMqIaFyL3Q4HZ3tpAb9uKV7DHiz-MvEd86Rx7aBPzkdhTTxg0eqZ83gDqvce2ogXwmvj9iKo3gqfbMCKCBqvXOjMn-f72GFa_NLbIU34A1420lkTmit0vhM2wPVJJ-jtfrldrJL188PjYr5OOpqmMQFa6iItORSZYqrKKOS5JopLDqSQWUmkFJpxshOU65wwyiVQVjGgklQ6VWyC7o65nXefPYRYNyYosFa04PpQ04plw0U8YwN6e0J72YCuO2-aYXL9fx37BZwUcFg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2934273643</pqid></control><display><type>article</type><title>Association of soluble ST2 Level with 6-month Mortality and/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Gunes, Hakan ; Gunes, Handan ; Dagli, Musa ; Kirişçi, Mehmet ; Özbek, Meryem ; Atilla, Nurhan ; Yılmaz, Mehmet Birhan</creator><creatorcontrib>Gunes, Hakan ; Gunes, Handan ; Dagli, Musa ; Kirişçi, Mehmet ; Özbek, Meryem ; Atilla, Nurhan ; Yılmaz, Mehmet Birhan</creatorcontrib><description>The association of soluble suppression of tumorigenesis-2 (sST2) levels with prognosis in pulmonary embolism (PE) is unknown. This study aimed to investigate the relationship between sST2 levels in patients with acute PE and 6-month mortality and recurrent hospitalizations. This prospective study included 100 patients with acute PE. Patients were classified into two groups according to 6-month mortality and the presence of recurrent Cardiovascular-Related hospitalizations. Two groups were compared. A p-value of 0.05 was considered statistically significant. Soluble ST2 levels were significantly higher in the group with mortality and recurrent hospitalizations. (138.6 ng/mL (56.7-236.8) vs. 38 ng/mL (26.3-75.4); p&lt;0.001) The best cut-off threshold for sST2 levels in the prediction of a composite outcome of 6-month mortality and/or recurrent Cardiovascular-Related hospitalization was found to be &gt;89.9 with a specificity of 90.6% and a sensitivity of 65.2%, according to the receiver operating characteristic curve (area under the curve = 0.798; 95% CI, 0.705-0.891; p &lt;0.0001). After adjusting for confounding factors that were either statistically significant in the univariate analysis or for the variables correlated with the sST2 levels, sST2 level (OR = 1.019, 95% CI: 1.009-1.028, p 0.001) and C-reactive protein (CRP ) (OR = 1.010, 95% CI: 1.001-1.021, p = 0.046) continued to be significant predictors of 6-month mortality and/or recurrent Cardiovascular-Related hospitalization in the multiple logistic regression model via backward stepwise method. Soluble ST2 level seems to be a biomarker to predict 6-month mortality and/or recurrent Cardiovascular-Related hospitalization in patients with acute PE.</description><identifier>EISSN: 1678-4170</identifier><identifier>DOI: 10.36660/abc.20230040</identifier><identifier>PMID: 38422305</identifier><language>eng ; por</language><publisher>Brazil</publisher><ispartof>Arquivos brasileiros de cardiologia, 2024, Vol.121 (2), p.e20230040-e20230040</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-3853-5046</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38422305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gunes, Hakan</creatorcontrib><creatorcontrib>Gunes, Handan</creatorcontrib><creatorcontrib>Dagli, Musa</creatorcontrib><creatorcontrib>Kirişçi, Mehmet</creatorcontrib><creatorcontrib>Özbek, Meryem</creatorcontrib><creatorcontrib>Atilla, Nurhan</creatorcontrib><creatorcontrib>Yılmaz, Mehmet Birhan</creatorcontrib><title>Association of soluble ST2 Level with 6-month Mortality and/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism</title><title>Arquivos brasileiros de cardiologia</title><addtitle>Arq Bras Cardiol</addtitle><description>The association of soluble suppression of tumorigenesis-2 (sST2) levels with prognosis in pulmonary embolism (PE) is unknown. This study aimed to investigate the relationship between sST2 levels in patients with acute PE and 6-month mortality and recurrent hospitalizations. This prospective study included 100 patients with acute PE. Patients were classified into two groups according to 6-month mortality and the presence of recurrent Cardiovascular-Related hospitalizations. Two groups were compared. A p-value of 0.05 was considered statistically significant. Soluble ST2 levels were significantly higher in the group with mortality and recurrent hospitalizations. (138.6 ng/mL (56.7-236.8) vs. 38 ng/mL (26.3-75.4); p&lt;0.001) The best cut-off threshold for sST2 levels in the prediction of a composite outcome of 6-month mortality and/or recurrent Cardiovascular-Related hospitalization was found to be &gt;89.9 with a specificity of 90.6% and a sensitivity of 65.2%, according to the receiver operating characteristic curve (area under the curve = 0.798; 95% CI, 0.705-0.891; p &lt;0.0001). After adjusting for confounding factors that were either statistically significant in the univariate analysis or for the variables correlated with the sST2 levels, sST2 level (OR = 1.019, 95% CI: 1.009-1.028, p 0.001) and C-reactive protein (CRP ) (OR = 1.010, 95% CI: 1.001-1.021, p = 0.046) continued to be significant predictors of 6-month mortality and/or recurrent Cardiovascular-Related hospitalization in the multiple logistic regression model via backward stepwise method. Soluble ST2 level seems to be a biomarker to predict 6-month mortality and/or recurrent Cardiovascular-Related hospitalization in patients with acute PE.</description><issn>1678-4170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo1kDtPwzAUhS0kREthZEUeWdI6duIkY1UVilQEKmWO_LgVRk4cbKeo7Pxvglqms3znoYPQTUqmjHNOZkKqKSWUEZKRMzROeVEmWVqQEboM4YMQSguWX6ARKzM6UPkY_cxDcMqIaFyL3Q4HZ3tpAb9uKV7DHiz-MvEd86Rx7aBPzkdhTTxg0eqZ83gDqvce2ogXwmvj9iKo3gqfbMCKCBqvXOjMn-f72GFa_NLbIU34A1420lkTmit0vhM2wPVJJ-jtfrldrJL188PjYr5OOpqmMQFa6iItORSZYqrKKOS5JopLDqSQWUmkFJpxshOU65wwyiVQVjGgklQ6VWyC7o65nXefPYRYNyYosFa04PpQ04plw0U8YwN6e0J72YCuO2-aYXL9fx37BZwUcFg</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Gunes, Hakan</creator><creator>Gunes, Handan</creator><creator>Dagli, Musa</creator><creator>Kirişçi, Mehmet</creator><creator>Özbek, Meryem</creator><creator>Atilla, Nurhan</creator><creator>Yılmaz, Mehmet Birhan</creator><scope>NPM</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3853-5046</orcidid></search><sort><creationdate>2024</creationdate><title>Association of soluble ST2 Level with 6-month Mortality and/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism</title><author>Gunes, Hakan ; Gunes, Handan ; Dagli, Musa ; Kirişçi, Mehmet ; Özbek, Meryem ; Atilla, Nurhan ; Yılmaz, Mehmet Birhan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-e28d7186e74c3c942e55d0c6b6e07b480bbad360fa26d50326be2393e2b09d1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; por</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gunes, Hakan</creatorcontrib><creatorcontrib>Gunes, Handan</creatorcontrib><creatorcontrib>Dagli, Musa</creatorcontrib><creatorcontrib>Kirişçi, Mehmet</creatorcontrib><creatorcontrib>Özbek, Meryem</creatorcontrib><creatorcontrib>Atilla, Nurhan</creatorcontrib><creatorcontrib>Yılmaz, Mehmet Birhan</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Arquivos brasileiros de cardiologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gunes, Hakan</au><au>Gunes, Handan</au><au>Dagli, Musa</au><au>Kirişçi, Mehmet</au><au>Özbek, Meryem</au><au>Atilla, Nurhan</au><au>Yılmaz, Mehmet Birhan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of soluble ST2 Level with 6-month Mortality and/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism</atitle><jtitle>Arquivos brasileiros de cardiologia</jtitle><addtitle>Arq Bras Cardiol</addtitle><date>2024</date><risdate>2024</risdate><volume>121</volume><issue>2</issue><spage>e20230040</spage><epage>e20230040</epage><pages>e20230040-e20230040</pages><eissn>1678-4170</eissn><abstract>The association of soluble suppression of tumorigenesis-2 (sST2) levels with prognosis in pulmonary embolism (PE) is unknown. This study aimed to investigate the relationship between sST2 levels in patients with acute PE and 6-month mortality and recurrent hospitalizations. This prospective study included 100 patients with acute PE. Patients were classified into two groups according to 6-month mortality and the presence of recurrent Cardiovascular-Related hospitalizations. Two groups were compared. A p-value of 0.05 was considered statistically significant. Soluble ST2 levels were significantly higher in the group with mortality and recurrent hospitalizations. (138.6 ng/mL (56.7-236.8) vs. 38 ng/mL (26.3-75.4); p&lt;0.001) The best cut-off threshold for sST2 levels in the prediction of a composite outcome of 6-month mortality and/or recurrent Cardiovascular-Related hospitalization was found to be &gt;89.9 with a specificity of 90.6% and a sensitivity of 65.2%, according to the receiver operating characteristic curve (area under the curve = 0.798; 95% CI, 0.705-0.891; p &lt;0.0001). After adjusting for confounding factors that were either statistically significant in the univariate analysis or for the variables correlated with the sST2 levels, sST2 level (OR = 1.019, 95% CI: 1.009-1.028, p 0.001) and C-reactive protein (CRP ) (OR = 1.010, 95% CI: 1.001-1.021, p = 0.046) continued to be significant predictors of 6-month mortality and/or recurrent Cardiovascular-Related hospitalization in the multiple logistic regression model via backward stepwise method. Soluble ST2 level seems to be a biomarker to predict 6-month mortality and/or recurrent Cardiovascular-Related hospitalization in patients with acute PE.</abstract><cop>Brazil</cop><pmid>38422305</pmid><doi>10.36660/abc.20230040</doi><orcidid>https://orcid.org/0000-0003-3853-5046</orcidid></addata></record>
fulltext fulltext
identifier EISSN: 1678-4170
ispartof Arquivos brasileiros de cardiologia, 2024, Vol.121 (2), p.e20230040-e20230040
issn 1678-4170
language eng ; por
recordid cdi_proquest_miscellaneous_2934273643
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central; Alma/SFX Local Collection
title Association of soluble ST2 Level with 6-month Mortality and/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T02%3A49%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20soluble%20ST2%20Level%20with%206-month%20Mortality%20and/or%20Recurrent%20Cardiovascular-Related%20Hospitalization%20in%20Pulmonary%20Embolism&rft.jtitle=Arquivos%20brasileiros%20de%20cardiologia&rft.au=Gunes,%20Hakan&rft.date=2024&rft.volume=121&rft.issue=2&rft.spage=e20230040&rft.epage=e20230040&rft.pages=e20230040-e20230040&rft.eissn=1678-4170&rft_id=info:doi/10.36660/abc.20230040&rft_dat=%3Cproquest_pubme%3E2934273643%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2934273643&rft_id=info:pmid/38422305&rfr_iscdi=true